Literature DB >> 8449897

Role of myocyte-specific enhancer-binding factor (MEF-2) in transcriptional regulation of the alpha-cardiac myosin heavy chain gene.

E A Adolph1, A Subramaniam, P Cserjesi, E N Olson, J Robbins.   

Abstract

The intergenic region between the mouse alpha-cardiac myosin heavy chain and beta-myosin heavy chain genes has previously been shown to direct expression of the bacterial chloramphenicol acetyltransferase reporter gene in transgenic mice in a tissue-specific manner. Sequence analyses located a putative myocyte-specific enhancer-binding factor (MEF-2) site situated in the regulatory region of this gene proximal to the start site of transcription. The role of this element in directing the cardiac compartment-specific expression of the transgene was assessed. The polymerase chain reaction was used to perform substitution mutagenesis of the MEF-2 binding site, and lack of MEF-2 binding was confirmed by gel retardation assays. The resultant construct was used to generate transgenic mice. Surprisingly, transgene expression was not down-regulated, but was significantly increased in the hearts of the MEF-2 mutant mice. In addition, cardiac-specific expression of the transgene was perturbed with significant levels of ectopic expression occurring in the aorta.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449897

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Transgenic over-expression of a motor protein at high levels results in severe cardiac pathology.

Authors:  J James; H Osinska; T E Hewett; T Kimball; R Klevitsky; S Witt; D G Hall; J Gulick; J Robbins
Journal:  Transgenic Res       Date:  1999-02       Impact factor: 2.788

2.  A conserved GATA motif in a tissue-specific DNase I hypersensitive site of the cardiac alpha-myosin heavy chain gene.

Authors:  W Y Huang; C C Liew
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia.

Authors:  G P Matherne; J Linden; A M Byford; N S Gauthier; J P Headrick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  Differential expression of the myocyte enhancer factor 2 family of transcription factors in development: the cardiac factor BBF-1 is an early marker for cardiogenesis.

Authors:  S Goswami; P Qasba; S Ghatpande; S Carleton; A K Deshpande; M Baig; M A Siddiqui
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

5.  Distinct gene expression patterns in skeletal and cardiac muscle are dependent on common regulatory sequences in the MLC1/3 locus.

Authors:  M J McGrew; N Bogdanova; K Hasegawa; S H Hughes; R N Kitsis; N Rosenthal
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

6.  Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene.

Authors:  Y Lee; B Nadal-Ginard; V Mahdavi; S Izumo
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

7.  Quantitative discrimination of MEF2 sites.

Authors:  J W Fickett
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

8.  Regulation of the human cardiac/slow-twitch troponin C gene by multiple, cooperative, cell-type-specific, and MyoD-responsive elements.

Authors:  T H Christensen; H Prentice; R Gahlmann; L Kedes
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

9.  Positive regulatory elements (HF-1a and HF-1b) and a novel negative regulatory element (HF-3) mediate ventricular muscle-specific expression of myosin light-chain 2-luciferase fusion genes in transgenic mice.

Authors:  K J Lee; R Hickey; H Zhu; K R Chien
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

10.  An in vivo analysis of transcriptional elements in the mouse alpha-myosin heavy chain gene promoter.

Authors:  H Rindt; A Subramaniam; J Robbins
Journal:  Transgenic Res       Date:  1995-11       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.